FDA approves label change for Depo-Provera, adding brain tumor warning

Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with ...
BioPharma Dive

FDA ‘proactively’ hands J&J a voucher; Pfizer issues 2026 forecasts

The FDA contacted J&J right after ASH to discuss using a special fast pass on a multiple myeloma regimen. Elsewhere, a new ...
PharmiWeb

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Continued Investment in Pipeline and Acquired Assets in 2026 to Fuel Long-Term GrowthReaffirms Full-Year 2025 Adjusted(1) Diluted EPS Guidance(2) and Revises Full-Year 2025 Revenue Guidance(2) to ...
BioSpace

Big Pharma Pushes FDA To Decouple Inspections From Drug Approval Applications

Representatives of companies including AbbVie, Eli Lilly, Johnson & Johnson and Merck have voiced concerns about the FDA’s ...